EX-23.1 5 ex23-1.htm

 

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM

 

We consent to the inclusion in this Registration Statement to Form S-1, Amendment 1 of our audit report dated March 29, 2023, with respect to the consolidated balance sheets of Therapeutic Solutions International, Inc. and subsidiaries as of December 31, 2022 and 2021, and the related consolidated statements of operations, changes in stockholders’ deficit, and cash flows for each of the years in the two-year period ended December 31, 2022.

 

Our report relating to those financial statements includes an emphasis of matter paragraph regarding substantial doubt as to the Company’s ability to continue as a going concern.

 

We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

 

Spokane, Washington

January 4, 2024